Dr. Phillipe Szapary from the University of Pennsylvania, School of Medicine, would be presenting the results of the clinical study with Gugulipid® at the 10th Annual Symposium of Complementary Healthcare, to be held at the Royal College of Physicians, 11 St Andrew’s Place, Regent’s Park, London, UK on November 21st and 22nd 2003.
His presentation titled “Metabolic effects of guggulipid: results from a randomised controlled trial” will summarize the results of a recent trial with Sabinsa’s trademarked product.
